Compound Library

Peptide / Metabolic

MOTS-c (Long-Acting)

PEGylated or extended-release MOTS-c. Mitochondrial-derived peptide with extended half-life. Same mechanism as standard MOTS-c — AMPK activation, insulin sensitisation, anti-aging — but with twice-weekly dosing.

Build protocol outline Open dose calculator TNHL ebooks
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.
Reference dose2–5 mg SubQ twice weekly
Half-life48 hours
Risk flagmoderate
Regulatory noteResearch-only flag

Side effects and watch-outs

  • Same as MOTS-c but longer duration
  • Fatigue during initiation
  • Injection site reaction
  • Monitor glucose (AMPK activation)